期刊文献+

小檗碱对Ⅱ型糖尿病大鼠降血糖作用的药效学研究 被引量:20

Pharmacodynamics Research on Berberine Reducing Blood Sugar in Rats with Type Ⅱ Diabetes
原文传递
导出
摘要 目的:研究小檗碱对Ⅱ型糖尿病大鼠的降血糖作用,为其临床应用提供实验依据。方法:采用正交实验法提取盐酸小檗碱;高脂高糖饲料饲养并结合链脲佐霉素(STZ)诱导建立Ⅱ型糖尿病大鼠模型,随机分为模型对照组、阳性对照组(二甲双胍)、盐酸小檗碱高、中、低剂量组,各组均灌胃给药,空白对照组与模型对照组灌服等量生理盐水,每日1次,连续14 d。于给药第14天各组动物禁食不禁水24 h,尾端取血,用血糖仪检测各组大鼠血糖浓度。结果:小檗碱能够降低糖尿病大鼠摄食量、饮水量、空腹血糖、糖耐量。结论:小檗碱能够改善糖尿病大鼠高血糖症状,具有良好的开发应用前景。 Objective : To study the hypoglycemic effect of berberine on rats with type Ⅱ diabetes, providing the experimental basis for its clinical application. Methods: Use the orthogonal experiment method to extract berberine hydrochloride. High fat and sugar feed combining chain urea with azithromycin (STZ) induced type Ⅱ diabetic rats models and we randomly divided the models into model control group, positive control group (metformin) and berberine hydrochloride high, medium and low doses groups. Each group was given the drugs by garage. The blank control group and model control group too the same amount of normal saline, once per day, for 14 consecutive days. In dosing day 14, fast water for 24 hours. Take out blood at the end of tails. The glucometer was used to detect blood glucose levels in rats. Results : Berberine can reduce diabetic rats' food intake,water quantity, fasting blood glucose and glucose tolerance. Conclusion: Berberine can relieve the symptoms of diabetic rats and has the good development prospect.
出处 《中华中医药学刊》 CAS 北大核心 2016年第10期2531-2533,共3页 Chinese Archives of Traditional Chinese Medicine
基金 台州市科技项目(1401ky32)
关键词 小檗碱 Ⅱ型糖尿病 大鼠 降血糖 药效学 berberine type Ⅱ diabetes rats reduce blood glucose pharmacodynamics
  • 相关文献

参考文献9

  • 1Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China[J].New England Journal of Medicine,2010,362(12):1090-1101.
  • 2ZHU Jiayin,CEN Xiaofeng,CHEN Xin,et al.The Research of Coptis Chinensis Alkaloids Synergies of Hypoglycemis Activity[J].Lishizhen Medicine and Materia Medica Research,2010,21(9):2282-2283.
  • 3Balzer BW,Graham CL,Craig ME,et al.Low glycaemic index dietary interventions in youth with cystic fibrosis:a systematic review and discussion of the clinical implications[J].Nutrients,2012,4(4):286-296.
  • 4徐叔云,卞如濂,陈修.药理实验方法学[M].3版.北京:人民卫生出版社,2005:1042-1043,1053.
  • 5王月芬,邢燕,叶山东.不同剂量吡格列酮对STZ糖尿病大鼠体内氧化应激的影响[J].中国糖尿病杂志,2012,20(6):466-468. 被引量:6
  • 6HAHM S W,PARK J,SON Y S.Opuntia humifusa stems lower bloodglucose and cholesterol levels in streptozotocin-induced diabetic rat[J].Nutrition Research,2011,31(6):479-487.
  • 7杜娟,柯亭羽,彭嘉睿,赵玲,赵黎莉,李孔龙.大鼠2型糖尿病模型制备方法探讨[J].昆明医科大学学报,2014,35(9):13-16. 被引量:6
  • 8郭婕,张国.2002年降血糖中药研究进展[J].中医药信息,2005,22(2):26-27. 被引量:7
  • 9陈远航,邓诗清,黄小玲.黄连素的降血糖药效学试验与临床观察[J].中国实用医药,2006,1(1):23-25. 被引量:27

二级参考文献39

  • 1[2]Jonas Jc,Sharma A,Hasenkam P W,et al:chionic hyperglycemia triggers loss of pancreatic β-cell differentiation in an aminal model of diabetes Biol Chem,1999,274:14112-14121.
  • 2Menon V,RamM,Dorn J, et al. Oxidative stress and glucose levels in a population-based sample. Diabet Med, 2004, 21: 1346-1352.
  • 3Ros RD, Assaloni R, Ceriello A. The preventive antioxidant action of thiazolidinediones : a new therapeutic prospect in diabe tes and insulin resistance. Diabet Med, 2004, 21:1249-1252.
  • 4Le NA. Hyperlipidaemia and cardiovascular disease: oxidative damage and atherosclerosis. Curr Opin Lipidol, 2006, 17: 92-94.
  • 5Ohashi M, Runge MS, Faraci FM, et al. MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice. Arte rioscler Thromb Vasc Biol, 2006, 26:2331-2336.
  • 6SAVAGE D B, PETERSEN K F, SHULMAN G I. Mecha- nisms of Insulin Resistance in Humans and Possible Links With Inflammation[ J ]. Hypertension, 2005,45 (3) : 828- 833.
  • 7WILD S, ROGLIC G, GREEN A, et al. Global Prevalence of diabetes : estimates for the year 2000 and projections for 2030[J]. Diabetes Care,2004,27(5):1 047-1 053.
  • 8BLONDEL O, BAILBE D, PORTHA B. Insulin resisitance in rats with noninsulin-dependent diabetes induced by neotatal (5days) streptcotocin: evidence foe reversal following phor/zing reatment [J]. Metabolism,1990,29 (8):787-789.
  • 9UNGER R H, OREI L. Disease of liporegulation: new per- spective on obesity and related disorders [J]. FASEB J, 2002,12(6):312-315.
  • 10McganyjdBantinglecture2001: dysregulation of fatty acid m- etabolism in the etiology of type 2 diabetes [J]. Diabetes, 2002,51(16):7-18.

共引文献90

同被引文献319

引证文献20

二级引证文献354

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部